Agreed ... the dates are vague, again ... or apparently delayed, again. But if you can't give exact dates ... then you can't. That maybe another issue. I'll take your edits ... but, I was happy to read the technical differentiation which I thought was more approachable for the non-technical person. There are 50 vaccines out there ... we get NO mainstream press. We need differentiation and to educate lay people, financial investors, and the non-financial and financial media. Just looking like another vaccine in the tide of vaccines is non-news. I don't think this PR was meant to kickstart the SP. I think we are building to the CC ... but that absolutely must be rock solid! Those have been absolute non-events at best.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links